RIGL Rigel Pharmaceuticals Inc climbs two percent after Q4 2025 results even as EPS falls short of analyst forecasts What Northern NAK said about inventory management Q3 2025 Earnings Beat Estimates CSV Carriage revenue climbs 33 as stock rises 19 despite earnings miss